With the vision to make life science matter and innovation happen, the cluster management established a clear strategy to become the leading European life science cluster, attracting global investment and talent.

BioRN establishes initiatives to nurture and extend networks between the key regional innovation stakeholders and towards other innovative ecosystems worldwide, with regular networking events and working groups. It stands for the promotion and visibility of the Life Science region at national and international level. Through a proactive dialog with public (health) authorities, BioRN influences policies, attracts investment and establishes new infrastructures in the biotechnology and healthcare field. BioRN is the central point of contact for external enquiries regarding Life Science topics and support inter-institutional initiatives to facilitate applied biosciences in the region, to foster health innovations and to create a rich translational ecosystem. BioRN especially leverages the unique combination of global pharmaceutical companies and leading academic institutions . BioRN initiates and manages different programmes to support the development of (academic) research ideas through all necessary development stages.

Mediated and supported by BioRN, Evotec established in 2021 the beLAB2122 BRIDGE. beLAB2122 is a new public-private partnership between the leading academic institutions of the Rhine-Main-Neckar region, Evotec and Bristol Myers Squibb to identify, fund and execute novel disease modifying therapeutic projects with the goal to develop these to new spinout companies.
BioRN is the initiator of Biolabs Heidelberg as well. BioLabs will offer premium on demand wet laboratories and office spaces to early-stage life-science startups with direct access to a network of industry parters and investors. The staged opening is planned from December 2021 to early 2022.